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Abstract: This is a report of a middle-aged male with blepharochalasis, who was successfully 
treated with oral acetazolamide. To our knowledge, this is the ﬁ  rst case in the literature reporting 
the beneﬁ  ts of the use of acetazolamide in the treatment of blepharochalasis.
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Introduction
Blepharochalasis is a rare condition that usually affects younger individuals and is 
characterized by lax, thin and wrinkled eyelid skin (Held and Schneiderman 1990; 
Piffaretti and Haeﬂ  iger 2004). The methods described to manage the cosmetic appear-
ance of the skin involves the use of steroids and surgery for blepharoplasty, with or 
without aponeurotic repair for persistent ptosis. These methods have met with only 
limited success. We report a case of a middle-aged patient with blepharochalasis, who 
was successfully treated with oral acetazolamide.
Case report
A 57-year old man was referred to the Eye Department in November 2003 because of 
a history of persisting periorbital swelling over a 4-year period, that tended to improve 
towards the end of the day. At the eye clinic, he presented with bilateral painless peri-
orbital edema and some degree of erythema (Figure 1a). The patient was a controlled 
hypertensive on bendroﬂ  uazide and enalapril; he also suffered from sleep apnea and 
renal calculi. He had been previously investigated at the Dermatology and lymphedema 
clinics but no signiﬁ  cant underlying abnormalities were identiﬁ  ed.
From the clinical examination and the long history of regular swelling, the diag-
nosis of bilateral blepharochalasis was made. Management was conservative with no 
treatment at the beginning.
Three months later the appearances had not changed and he was then started on 
medical treatment. Surgical correction was not indicated because of the risk of recur-
rent edema in the immediate post operative period. The patient was initially started on 
low dose of systemic steroids but with no improvement and, after consultation with 
the urologists, the patient was then changed to oral acetazolamide 250 mg SR daily.
After 4-months, oral acetazolamide proved to be effective in reducing the periorbital 
edema and improving the symptoms of discomfort in the periorbital region. Due to 
the side effects of acetazolamide (paraesthesiae), the treatment was tapered off over 
the following month (250 mg acetazolamide SR on alternate days). Nine months from 
presentation, the periorbital swelling had clearly reduced and the patient remained 
asymptomatic and was happier with his appearance (Figure 1b). He still refused to 
consider blepharoplasty surgery, which was offered at this stage to debulk the remaining 
skin tissue. At his last follow up appointment, now 3-years since presentation, he Clinical Ophthalmology 2007:1(3) 332
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remains asymptomatic and is still not willing to consider 
surgical intervention.
Comment
To our knowledge, this is the ﬁ  rst case in the literature report-
ing the beneﬁ  ts of the use of acetazolamide in the treatment 
of blepharochalasis.
Blepharochalasis comes from the Greek words blepharo 
(= eyelid) and chalasis (= slackening) (Albert and Jakobiec 
1999, p 112). It describes recurrent attacks of idiopathic tran-
sient painless edema of the upper eyelids, that may produce 
permanent tissue changes. Because of recurrences, the eyelid 
skin of patients becomes thin and wrinkled, simulating the 
appearances of dermatochalasis (Held and Schneiderman 
1990). In this case, the presence of prior chronic recurrent 
eyelid edema was an important differentiating feature. 
Similarly, in a review of 30 cases of blepharochalasis, the 
histopathology (reported as variable picture of epithelial 
atrophy, vasculitis and loss of elastic ﬁ  bers) did not aid in 
differentiating the condition from angioedema, lymphedema 
or dermatochalasis (Collin 1991). The diagnosis again was 
based on clinical features of intermittent attacks of localized 
swelling affecting one or more eyelids, associated with thin-
ning of the eyelid skin (Bergin et al 1988).
A pathophysiological explanation which considers bleph-
arochalasis as a localized angioedema has been proposed 
(Jordan 1992; Piest 1999). Furthermore, it has been reported 
that eye diseases have been associated with sleep apnea 
syndrome, upper lid ptosis and blepharochalasis (Mojon 
2001). In our patient, sleep apnea could have also played a 
role in his blepharochalasis.
Standard practice has been to address the joint problem of 
recurrent inﬂ  ammation and redundant skin. Various authors 
have reported effective use of systemic steroids and the 
need for blepharoplasty, which may require to be repeated 
(Collin et al 1979; Bergin et al 1988; Collin 1991). Our 
attempt to treat with steroids was ineffective and potential 
problems with fragile control of his hypertension prompted 
us to discontinue this form of management. Surgery was 
not employed, as this patient has persistently declined any 
surgical intervention. However, surgical repair of blepharo-
chalasis, an option usually kept for the quiescent stage, may 
be complicated by repeated episodes of inﬂ  ammation and 
edema, causing recurrence of ptosis and other eyelid changes 
(Collin et al 1979; Collin 1991).
There is, therefore, no well deﬁ  ned, established treatment 
protocol for the management of blepharochalasis. Treatment 
with steroids has been described as effective, on the basis of 
their powerful anti-inﬂ  ammatory properties (Habal 1985). 
The treatment, which we have given using oral acetazolamide, 
promoted the resolution of the edema, but the exact mechanism 
is not fully understood: it seems that the improvement was 
likely to be based on its diuretic properties (BNF 2005).
Here we presented a patient with blepharochalasis 
with significant improvement after treatment with oral 
acetazolamide. We suggest that acetazolamide, not having 
the side effects of steroids, is a non-invasive alternative 
approach for treating patients with blepharochalasis, seeking 
cosmetic improvement but not keen on surgery. This could 
be considered at a later stage in development, when all signs 
of inﬂ  ammation have resolved.
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